UBS O'Connor’s Protalix BioTherapeutics PLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-445,171
Closed -$1.99M 937
2021
Q1
$1.99M Buy
445,171
+295,171
+197% +$1.37M 0.03% 475
2020
Q4
$544K Sell
150,000
-150,000
-50% -$538K 0.01% 482
2020
Q3
$1.16M Sell
300,000
-372,035
-55% -$1.35M 0.03% 216
2020
Q2
$2.55M Buy
+672,035
New +$2.3M 0.06% 208
2018
Q1
Sell
-32,448
Closed -$215K 356
2017
Q4
$215K Hold
32,448
﹤0.01% 274
2017
Q3
$188K Hold
32,448
﹤0.01% 316
2017
Q2
$272K Buy
+32,448
New +$305K ﹤0.01% 356
2017
Q1
Sell
-400,000
Closed -$1.78M 483
2016
Q4
$1.78M Buy
+400,000
New +$1.79M 0.03% 316

Other funds holding PLX